Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: patents
USPTO Proposes Incentivizing Humanitarian Technologies and Licensing
On Monday, the PTO requested comments on the use of the IP system to incentivize humanitarian technologies and licensing to benefit “impoverished population[s].” A grab-bag of concepts and ideas was set forth, with perhaps the most concrete (and marginally useful) … Continue reading
Pharmaceutical Patent Protection and Enforcement Conference
Warren Woessner will be a speaker on September 28th at Q1 Productions’ “Pharmaceutical Patent Protection and Enforcement Conference” in Baltimore, MD. Warren will speak on “Myriad: The District Court’s Opinion & Road Ahead”, a topic that has been the subject … Continue reading
Posted in Conferences and Classes
Tagged intellectual property, patents, Pharmaceutical law, Warren Woessner
Leave a comment
USPTO Issues “2010 KSR Guidelines Update”
On September 1st, the Office of Patent Legal Administration (I didn’t know there was one) issued 17 pages in the Fed. Reg. (Vol. 75, 53643) updating its obviousness guidelines. (A copy of the guidelines is found at the end of … Continue reading
Posted in Obviousness
Tagged biotechnology, biotechnology law, biotechnology news, intellectual property, ip, IP law tools, KSR, Patent Law, patents, USPTO, Warren Woessner
1 Comment
University IP In The News – Expedited Examination And March-In Request
On July 29th, Rep. Frank Wolf (D.-Va.) introduced H.R. 5980 that would give priority to examination of patent applications filed by U.S. universities and by their “patent holding companies.” The definition of the latter seems a bit vague, but is … Continue reading
Posted in Tech Transfer
Tagged biotechnology, biotechnology law, biotechnology news, DHHS, Fabrazyme, Fabry Disease, Frank Wolf, H.R. 5980, intellectual property, ip, Patent Law, patents, WARF, Warren Woessner
Leave a comment